🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users administering products of unknown origin.

Several experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.

After moments of entering one group, a seller shared contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Information and Pricing

Within these communities, posts display dark colored parcels with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When asked how much time a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to potentially serious medical dangers”.